Mercy Hospital of Philadelphia — Philadelphia, Pennsylvania

Mercy Hospital of Philadelphia is a clinical research site located in Philadelphia, Pennsylvania, United States 19143.

Crixeo Health Trust Score: 72/100 (FAIR). This profile has not yet been claimed by the site owner.

Mercy Hospital of Philadelphia has participated in 7 clinical trials with 1 currently active.

Therapeutic areas: Node Positive HER2 Negative Breast Cancer, HER2/Neu Positive, Progesterone Receptor Positive.

Sponsors: Alliance for Clinical Trials in Oncology, National Cancer Institute (NCI), SWOG Cancer Research Network.

Sponsor Feasibility Report

Trust Score: 72/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Mercy Hospital of Philadelphia?

Mercy Hospital of Philadelphia has a Crixeo Trust Score of 72/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Mercy Hospital of Philadelphia conducted?

Mercy Hospital of Philadelphia has 7 clinical trials on record, with 1 currently active. Their work covers Node Positive HER2 Negative Breast Cancer, HER2/Neu Positive, Progesterone Receptor Positive.

Is Mercy Hospital of Philadelphia accredited by Crixeo Health?

Yes — Mercy Hospital of Philadelphia holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Mercy Hospital of Philadelphia?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.